EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical imaging diagnosis of pulmonary cryptococcosis with different therapeutic responses

Yan-Li Zhang, Chao Ran, Wei Li

Scientific Reports · 2024

DOI: 10.1038/s41598-024-80875-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Yan-Li Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China. Hauptthemen laut MEDLINE: Cryptococcosis, Lung Diseases, Fungal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We aimed to differentiate and evaluate the clinical imaging features of pulmonary cryptococcosis with different therapeutic responses. The clinical imaging data of 70 patients with PC (complete response PC 37 cases and incomplete response PC 33 cases) were collected and compared to determine the independent risk factors for different therapeutic responses, and their diagnostic performances were verified by receiver operating characteristic curve analysis. Compared with complete response PC, incomplete response PC was more common with immunosuppression (10.8% vs. 45.5%, P = 0.001), intermediate progress (8.1% vs. 39.4%, P = 0.002), bilateral distribution (21.6% vs. 78.8%, P < 0.001), consolidation-interstitial pattern (10.8% vs. 42.4%, P = 0.003), pleural effusion (0 vs. 27.3%, P = 0.002) and mediastinal lymphadenopathy (0 vs. 24.2%, P = 0.005). Multivariate logistic regression showed that immunosuppression, intermediate progress, and bilateral distribution were independent risk factors, with low to moderate areas under curves (AUC, 0.656-0.786). Their combined performance was good with an AUC of 0.888. The diverse clinical imaging features can reflect the therapeutic response of PC. Immunosuppression, intermediate progress, and bilateral distribution were independent risk factors. Their combination can significantly improve diagnostic effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptococcosisLung Diseases, FungalHumansMaleFemaleMiddle AgedAdultAgedTomography, X-Ray ComputedROC CurveRisk FactorsRetrospective StudiesTreatment OutcomeAntifungal Agents

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
  • Department of Radiology, Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China.
  • Medical Imaging Department, Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368, Hanjiang Middle Road, Hanjiang District, Yangzhou, 225100, China. liweiqd830127@163.com.

Zitieren

APA

Zhang, Y. L., Ran, C., & Li, W. (2024). Clinical imaging diagnosis of pulmonary cryptococcosis with different therapeutic responses. Scientific Reports. https://doi.org/10.1038/s41598-024-80875-4

Vancouver

Zhang YL, Ran C, Li W. Clinical imaging diagnosis of pulmonary cryptococcosis with different therapeutic responses. Scientific Reports. 2024. doi:10.1038/s41598-024-80875-4

BibTeX
@article{Zhang2024,
  author = {Zhang, Yan-Li and Ran, Chao and Li, Wei},
  title = {Clinical imaging diagnosis of pulmonary cryptococcosis with different therapeutic responses},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-80875-4}
}
Kostenlos starten →